Doctors test First-Ever spinal fluid vaccine for deadly breast cancer brain spread
NCT ID NCT05809752
Summary
This is a first-in-human safety study testing a new immune-boosting vaccine for breast cancer that has spread to the membranes surrounding the brain and spinal cord. Researchers will give the vaccine directly into the spinal fluid of up to 18 patients to find the highest dose that can be given safely. The goal is to see if this approach can help control this aggressive form of cancer spread and extend survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2-POSITIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Memorial Sloan Kettering Cancer Center
WITHDRAWNNew York, New York, 10065, United States
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact
Contact
Contact
-
Roswell Park Comprehensive Cancer Center
WITHDRAWNBuffalo, New York, 14263, United States
Conditions
Explore the condition pages connected to this study.